{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:56:42Z","timestamp":1790661402451,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BE 7517\/3\u20131"],"award-info":[{"award-number":["BE 7517\/3\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FU 356\/12\u20132"],"award-info":[{"award-number":["FU 356\/12\u20132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 58,219\/68-1 FUGG"],"award-info":[{"award-number":["INST 58,219\/68-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TA 275\/8\u20131"],"award-info":[{"award-number":["TA 275\/8\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23428","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:59:32Z","timestamp":1702335572000},"page":"e23428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Plasma levels of chemokines decrease during elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-6602","authenticated-orcid":false,"given":"Dirk","family":"Westh\u00f6lter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Pipping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4778-4796","authenticated-orcid":false,"given":"Jonas","family":"Raspe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivagurunathan","family":"Sutharsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Stra\u00dfburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1259-8911","authenticated-orcid":false,"given":"Matthias","family":"Welsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.heliyon.2023.e23428_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","article-title":"Inflammation in cystic fibrosis lung disease: pathogenesis and therapy","volume":"14","author":"Cantin","year":"2015","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"S3","key":"10.1016\/j.heliyon.2023.e23428_bib2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ppul.24129","article-title":"Inflammation in cystic fibrosis: an update","volume":"53","author":"Roesch","year":"2018","journal-title":"Pediatr. Pulmonol."},{"issue":"10212","key":"10.1016\/j.heliyon.2023.e23428_bib3","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23428_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(21)00454-9","article-title":"Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial","volume":"10","author":"Sutharsan","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.heliyon.2023.e23428_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2021.05.001","article-title":"Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis","author":"Westh\u00f6lter","year":"2021","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc. Published online"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23428_bib6","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23428_bib7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.202012-4332LE","article-title":"Ivacaftor and airway inflammation in preschool children with cystic fibrosis","volume":"204","author":"McNally","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2023.e23428_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54556","article-title":"Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis","volume":"9","author":"Jarosz-Griffiths","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2023.e23428_bib9","article-title":"Normalization of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis","volume":"1","author":"Dhote","year":"2022","journal-title":"Eur Respir J. Published online January"},{"key":"10.1016\/j.heliyon.2023.e23428_bib10","article-title":"Cystic fibrosis macrophage function and clinical outcomes after elexacaftor\/tezacaftor\/ivacaftor","volume":"1","author":"Zhang","year":"2022","journal-title":"Eur Respir J. Published online January"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23428_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00725-2022","article-title":"Elexacaftor\/tezacaftor\/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis","volume":"61","author":"Cavinato","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2023.e23428_bib12","article-title":"Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis","author":"Sheikh","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.heliyon.2023.e23428_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107437","article-title":"Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor\/Tezacaftor\/Ivacaftor therapy","volume":"14","author":"Westh\u00f6lter","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23428_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23428_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/thorax-2022-219943","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on airway and systemic inflammation in cystic fibrosis","volume":"78","author":"Casey","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2023.e23428_bib16","article-title":"Moving the dial on airway inflammation in response to Trikafta\u00ae in adolescents with cystic fibrosis","volume":"4","author":"Lepissier","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23428_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/CMR.00014-10","article-title":"The airway epithelium: soldier in the fight against respiratory viruses","volume":"24","author":"Vareille","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23428_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/10454411950060020101","article-title":"Chemokines, a family of chemotactic cytokines","volume":"6","author":"Groves","year":"1995","journal-title":"Crit. Rev. Oral Biol. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23428_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00178508","article-title":"Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis","volume":"34","author":"Brennan","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23428_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.201203-0507OC","article-title":"Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis","volume":"186","author":"Sagel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23428_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/hsz-2015-0271","article-title":"Neutrophils in cystic fibrosis","volume":"397","author":"Laval","year":"2016","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23428_bib22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/biom5031386","article-title":"Transcription of interleukin-8: how altered regulation can affect cystic fibrosis lung disease","volume":"5","author":"Jundi","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2023.e23428_bib23","article-title":"Multiplex cytokine profiling of stimulated mouse splenocytes using a cytometric bead-based immunoassay platform","volume":"129","author":"Lehmann","year":"2017","journal-title":"J. Vis. Exp."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23428_bib24","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/en.2019-00340","article-title":"An accurate substitution method to minimize left censoring bias in serum steroid measurements","volume":"160","author":"Handelsman","year":"2019","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23428_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1203\/00006450-199308000-00010","article-title":"Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis","volume":"34","author":"Dean","year":"1993","journal-title":"Pediatr. Res."},{"issue":"6 Pt 1","key":"10.1016\/j.heliyon.2023.e23428_bib26","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1164\/ajrccm.152.6.8520783","article-title":"Inflammatory cytokines in cystic fibrosis lungs","volume":"152","author":"Bonfield","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"21","key":"10.1016\/j.heliyon.2023.e23428_bib27","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1091\/mbc.e12-06-0424","article-title":"Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia","volume":"23","author":"Veit","year":"2012","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23428_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/rmed.1999.0725","article-title":"Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children","volume":"94","author":"Wyatt","year":"2000","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23428_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1165\/ajrcmb.14.3.8845182","article-title":"Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78","volume":"14","author":"Bozic","year":"1996","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23428_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2119\/2007-00081.Adib-Conquy","article-title":"Neutrophils in cystic fibrosis display a distinct gene expression pattern","volume":"14","author":"Adib-Conquy","year":"2008","journal-title":"Mol. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23428_bib31","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23428_bib32","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/1521-4141(200107)31:7<1981::AID-IMMU1981>3.0.CO;2-X","article-title":"Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)\/CCL20 and MIP-3beta\/CCL19","volume":"31","author":"Scapini","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23428_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1165\/rcmb.2002-0272OC","article-title":"CCL20 is an inducible product of human airway epithelia with innate immune properties","volume":"29","author":"Starner","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23428_bib34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.chest.2019.05.017","article-title":"Proteomic profiling to identify blood biomarkers predictive of response to azithromycin in children and adolescents with cystic fibrosis","volume":"156","author":"Dong","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23428_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcf.2008.09.009","article-title":"Monocyte chemoattractant chemokines in cystic fibrosis","volume":"8","author":"Rao","year":"2009","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23428_bib36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/MCB.23.2.594-606.2003","article-title":"Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif","volume":"23","author":"Estell","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23428_bib37","doi-asserted-by":"crossref","first-page":"C700","DOI":"10.1152\/ajpcell.1999.276.3.C700","article-title":"Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression","volume":"276","author":"Schwiebert","year":"1999","journal-title":"Am J Physiol Physiol"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23428_bib38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","article-title":"Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis","volume":"133","author":"Takada","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23428_bib39","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.182.5.1301","article-title":"Human Mig chemokine: biochemical and functional characterization","volume":"182","author":"Liao","year":"1995","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23428_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jaci.2005.09.023","article-title":"Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis","volume":"117","author":"Hartl","year":"2006","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023106360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:24Z","timestamp":1790657964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023106360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023106360"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23428","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of chemokines decrease during elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23428"}}